www.sunovion.com Open in urlscan Pro
2600:9000:2251:fa00:e:732c:1680:93a1  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Skip to Main Content


 * HEALTH CARE PROFESSIONALS


 * PATIENTS

 * ENGLISH
    * CANADA > ENGLISH
    * CANADA > FRENCH

 * 
   


   PRODUCT INNOVATION
   
   
   * PRODUCT INNOVATION
   
   
     PIPELINE
     
     
     PSYCHIATRY
     
     
     NEUROLOGY
     
     
     ADDITIONAL THERAPIES
     
     
     SCIENTIFIC PUBLICATIONS
   
   
   CAREERS
   
   
   * CAREERS
   
   
     JOB SEARCH
     
     
     BENEFITS
     
     
     OUR CONNECTED CULTURE
     
     
     CAREER GROWTH
   
   
   PARTNERSHIPS
   
   
   * PARTNERSHIPS
   
   
     AFFILIATES
   
   
   RESPONSIBILITY
   
   
   * RESPONSIBILITY
   
   
     BUILDING COMMUNITIES
     
     
     ADVOCATING FOR PATIENTS
   
   
   ABOUT US
   
   
   * ABOUT US
   
   
     MISSION, VISION & VALUES
     
     
     PEOPLE & CULTURE
     
     
     EXECUTIVE LEADERSHIP
     
     
     DIVERSITY & INCLUSION
     
     
     CONTACT US
   
   
   NEWS & MEDIA
   
   
   * NEWS & MEDIA
   
   
     MEDIA KIT
   
   
   HEALTH CARE PROFESSIONALS
   
   
   PATIENTS


PATIENT-INSPIRED
PURPOSE. CNS
SCIENCE-DRIVEN
INNOVATION.

At Sunovion, we strive to serve and create value for patients every day. By
developing innovative therapies that treat serious Central Nervous System (CNS)
conditions, science leads the way—guiding us to a healthier tomorrow.

--------------------------------------------------------------------------------


OUR NEWS & MEDIA


JUN 15, 2023

Empowering the Next Generation of Innovators





APR 26, 2023

Sunovion and Otsuka Initiate Clinical Development of Ulotaront for the Treatment
of Generalized Anxiety Disorder





APR 3, 2023

Sumitomo Pharma Subsidiary Companies in the U.S., Including Sunovion, to Combine
and Form Sumitomo Pharma America



 * * Slide 1
   * Slide 2
   * Slide 3
 * See all news

About Us


DISCOVER SUNOVION

We are a patient-driven team with a strong track record of discovery,
development and commercialization of important psychiatric and neurological
therapies. We aim to improve the lives of people facing the enormous unmet needs
associated with these serious conditions. Our passion drives us, our mission
inspires us.

 * Learn more



Our Vision


LEAD THE WAY TO A HEALTHIER WORLD



Product Innovation


OUR THERAPEUTIC FOCUS

From our history of innovation to our future-forward approach to therapeutic
advancements, we are committed to supporting people with serious psychiatric and
neurological conditions live better lives. Today's developments pave the way for
tomorrow's discoveries.

 * Learn more




THERAPIES IN DEVELOPMENT

Uncover our latest developments as we expand our pipeline of innovative CNS
therapies.

Therapeutic Area Candidate Indication/Target Phase Psychiatry Ulotaront
(SEP-363856) Schizophrenia

Phase 3 75% complete

Psychiatry SEP-4199 Bipolar Depression

Phase 3 75% complete

Psychiatry Ulotaront
(SEP-363856) Adjunctive major depressive disorder

Phase 3 75% complete

Therapeutic Area Candidate Indication/Target Psychiatry Ulotaront
(SEP-363856) Schizophrenia

Phase 3 75% complete

Psychiatry SEP-4199 Bipolar Depression

Phase 3 75% complete

Psychiatry Ulotaront
(SEP-363856) Adjunctive major depressive disorder

Phase 3 75% complete

 * See full pipeline

Responsibility


BUILDING STRONGER
COMMUNITIES

Sunovion is committed to working with partners to support the local, regional,
and global community as part of our overall Corporate Social Responsibility
efforts. Our collaboration with various community organizations helps in
impactful ways to build stronger and healthier communities where we live and
work.

 * Read more


Careers


WHAT’S YOUR CALLING?

What drives you? We believe that our work is a privilege. Every day we have an
opportunity to apply our experiences and perspectives to create new treatments
that will help people with serious medical conditions.

 * Explore careers




WHAT IS
SUNOVION ANSWERS?

We believe in putting people first, which is why we created Sunovion Answers.
Our caring and skilled team is available to provide knowledge and resources to
help patients, caregivers, family members, or providers. We're committed to
finding solutions and connecting people to the information they need.

 * Get answers


 * * Product Innovation
   * Careers
   * Partnerships
   * Responsibility
   * About Us
   * News & Media
 * Patient Support SunovionSupport.com
   HCP Support SunovionProFile.com SunovionMedical.com
 * * Resources
   * Authorized Distributors
   * Procurement
   * Investigator Research Grants
   * Medical Education Grants
   * Sumitomo Pharma Co., Ltd.

 * * Contact Us
   * 
   * 
   * 
   * 

 * Terms of Use
 * Privacy Policy & Cookie Notice
 * Medical Disclaimer
 * Social Media Community Guidelines
 * Sources
 * Sitemap
 * Corporate Transparency Documents

SUNOVION, , and LATUDA are registered trademarks of Sumitomo Pharma Co., Ltd.
Sunovion Pharmaceuticals Inc. is a U.S. subsidiary of Sumitomo Pharma Co., Ltd.

APTIOM is a registered trademark of , used under license.

LONHALA and are registered trademarks of Sunovion Pharmaceuticals Inc. MAGNAIR
is a registered trademark of PARI Pharma GmbH, used under license.

eFlow and eLete are registered trademarks of PARI Pharma GmbH.

KYNMOBI and are registered trademarks of Sunovion Pharmaceuticals Inc.

© 2023 Sunovion Pharmaceuticals Inc. All rights reserved.



By clicking “Accept All Cookies”, you agree to the storing of cookies on your
device to enhance site navigation, analyze site usage, and assist in our
marketing efforts. Privacy Policy & Cookie Notice

Accept All Cookies Reject All
Cookies Settings



PRIVACY PREFERENCE CENTER


Sunovion | Page Not Found
Skip to Main Content
 * 
   


   PRODUCT INNOVATION
   
   
   * PRODUCT INNOVATION
   
   
     PIPELINE
     
     
     PSYCHIATRY
     
     
     NEUROLOGY
     
     
     ADDITIONAL THERAPIES
     
     
     SCIENTIFIC PUBLICATIONS
   
   
   CAREERS
   
   
   * CAREERS
   
   
     JOB SEARCH
     
     
     BENEFITS
     
     
     OUR CONNECTED CULTURE
     
     
     CAREER GROWTH
   
   
   PARTNERSHIPS
   
   
   * PARTNERSHIPS
   
   
     AFFILIATES
   
   
   RESPONSIBILITY
   
   
   * RESPONSIBILITY
   
   
     BUILDING COMMUNITIES
     
     
     ADVOCATING FOR PATIENTS
   
   
   ABOUT US
   
   
   * ABOUT US
   
   
     MISSION, VISION & VALUES
     
     
     PEOPLE & CULTURE
     
     
     EXECUTIVE LEADERSHIP
     
     
     DIVERSITY & INCLUSION
     
     
     CONTACT US
   
   
   NEWS & MEDIA
   
   
   * NEWS & MEDIA
   
   
     MEDIA KIT
   
   
   HEALTH CARE PROFESSIONALS
   
   
   PATIENTS

We are sorry, the link you have requested is not available.


 * HOME


 * PRODUCT INNOVATION
   
   
   * PIPELINE
     
     * CLINICAL TRIALS DISCLOSURE
     
     * EXPANDED ACCESS POLICY
   
   
   * PSYCHIATRY
   
   
   * NEUROLOGY
   
   
   * ADDITIONAL THERAPIES
   
   
   * SCIENTIFIC PUBLICATIONS


 * CAREERS
   
   
   * JOB SEARCH
   
   
   * BENEFITS
   
   
   * CAREER GROWTH


 * PARTNERSHIPS


 * RESPONSIBILITY
   
   
   * BUILDING COMMUNITIES
   
   
   * ADVOCATING FOR PATIENTS


 * ABOUT US
   
   
   * MISSION, VISION & VALUES
   
   
   * PEOPLE & CULTURE
     
     * EXECUTIVE LEADERSHIP
   
   
   * DIVERSITY & INCLUSION
   
   
   * CONTACT US


 * NEWSROOM
   
   
   * MEDIA KIT

 * * Product Innovation
   * Careers
   * Partnerships
   * Responsibility
   * About Us
   * News & Media
 * Patient Support SunovionSupport.com
   HCP Support SunovionProFile.com SunovionMedical.com
 * * Resources
   * Authorized Distributors
   * Procurement
   * Investigator Research Grants
   * Medical Education Grants
   * Sumitomo Pharma Co., Ltd.

 * * Contact Us
   * 
   * 
   * 
   * 

 * Terms of Use
 * Privacy Policy & Cookie Notice
 * Medical Disclaimer
 * Social Media Community Guidelines
 * Sources
 * Sitemap
 * Corporate Transparency Documents

SUNOVION, , and LATUDA are registered trademarks of Sumitomo Pharma Co., Ltd.
Sunovion Pharmaceuticals Inc. is a U.S. subsidiary of Sumitomo Pharma Co., Ltd.

APTIOM is a registered trademark of , used under license.

LONHALA and are registered trademarks of Sunovion Pharmaceuticals Inc. MAGNAIR
is a registered trademark of PARI Pharma GmbH, used under license.

eFlow and eLete are registered trademarks of PARI Pharma GmbH.

KYNMOBI and are registered trademarks of Sunovion Pharmaceuticals Inc.

© 2023 Sunovion Pharmaceuticals Inc. All rights reserved.


 * YOUR PRIVACY


 * MARKETING COOKIES


 * PERFORMANCE COOKIES


 * STRICTLY NECESSARY COOKIES

YOUR PRIVACY

When you visit any website, it may store or retrieve information on your
browser, mostly in the form of cookies. This information might be about you,
your preferences or your device and is mostly used to make the site work as you
expect it to. The information does not usually directly identify you, but it can
give you a more personalized web experience. Because we respect your right to
privacy, you can choose not to allow some types of cookies. Click on the
different category headings to find out more and change our default settings.
However, blocking some types of cookies may impact your experience of the site
and the services we are able to offer.
Privacy Policy & Cookie Notice

MARKETING COOKIES

Marketing Cookies


These cookies may be set through our site by our advertising partners. They may
be used by those companies to build a profile of your interests and show you
relevant adverts on other sites. They do not store directly personal
information, but are based on uniquely identifying your browser and internet
device. If you do not allow these cookies, you will experience less targeted
advertising.

Cookies Details‎

PERFORMANCE COOKIES

Performance Cookies


These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They help us to know which pages are the
most and least popular and see how visitors move around the site. All
information these cookies collect is aggregated and therefore anonymous. If you
do not allow these cookies we will not know when you have visited our site, and
will not be able to monitor its performance.

Cookies Details‎

STRICTLY NECESSARY COOKIES

Always Active

These cookies are necessary for the website to function and cannot be switched
off in our systems. They are usually only set in response to actions made by you
which amount to a request for services, such as setting your privacy
preferences, logging in or filling in forms. You can set your browser to block
or alert you about these cookies, but some parts of the site will not then work.
These cookies do not store any personally identifiable information.

Cookies Details‎
Back Button


BACK

Filter Button
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label

 * View Third Party Cookies
    * Name
      cookie name


Clear
checkbox label label
Apply Cancel
Confirm My Choices
Reject All Allow All



Sunovion is now Sumitomo Pharma America, Inc. (SMPA).

Learn More About SMPA

Continue To This Website